.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Harvard Business School
Mallinckrodt
Covington
Fish and Richardson
Healthtrust
Daiichi Sankyo
Federal Trade Commission
McKinsey

Generated: February 23, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to France Patent: 05 01989

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Amgen IncCORLANORivabradine hydrochlorideTABLET;ORAL206143-001Apr 15, 2015RXYesNo➤ Sign Up➤ Sign UpYYA METHOD FOR TREATING HEART FAILURE IN A HUMAN USING A CRYSTALLINE FORM OF IVABRADINE HYDROCHLORIDE
Amgen IncCORLANORivabradine hydrochlorideTABLET;ORAL206143-002Apr 15, 2015RXYesYes➤ Sign Up➤ Sign UpYYA METHOD FOR TREATING HEART FAILURE IN A HUMAN USING A CRYSTALLINE FORM OF IVABRADINE HYDROCHLORIDE
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist